| Financial Year |
March 31 2023 |
| Monetary Funds |
308,166,338.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
15,128,443.13 |
| Accounts Receivable |
1,373,306,975.68 |
| Advances to Suppliers |
79,350,306.90 |
| Other Receivables |
241,218,470.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
609,235,003.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
13,962,828.71 |
| Other Current Assets |
107,013,045.59 |
| Total Current Assets |
3,039,153,999.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
253,749,854.15 |
| Long-term Equity Investment |
9,421,600.96 |
| Investment Properties |
-- |
| Fixed Assetes |
165,439,304.07 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
345,133,236.15 |
| R&D expenses |
45,505,494.56 |
| Goodwill |
248,924,987.78 |
| Long-Term Deferred and Prepaid Expenses |
28,461,782.95 |
| Deferred Income Tax Assets |
218,774,658.66 |
| Other Non-Current Assets |
255,819.91 |
| Sub-Total of Non-Current Assets |
1,514,308,019.80 |
| Total Assets |
4,553,462,019.23 |
| Short-Term Loans |
1,201,201,678.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
32,288,136.95 |
| Accounts Payable |
1,801,962,206.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
64,512,149.31 |
| Taxes Payable |
62,309,797.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
304,638,146.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
58,835,935.24 |
| Other Current Liabilities |
26,791,827.57 |
| Sub-Total of Current Liabilities |
3,727,250,276.04 |
| Long-term Loans |
153,594,794.88 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,353,791.76 |
| Deferred Income Tax Liabilities |
12,797,363.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
232,055,312.55 |
| Total Liabilities |
3,959,305,588.59 |
| Paid-In Capital(Or Share Stock) |
374,400,000.00 |
| Capital Surplus |
2,057,734,085.05 |
| Surplus Reserve |
60,340,732.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,816,031,915.77 |
| Minority Stockholder's Interest |
-6,052,674.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
600,209,104.75 |
| Owner's Equity（Stockholder's Equity） |
594,156,430.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,553,462,019.23 |
